Cargando…
The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
MGMT-promoter methylation is associated with favorable outcome in glioblastoma. The aim of this study was to determine whether the absolute number of methylated Cytosine-Guanine-dinucleotide-(CpG-)sites within the DMR-2 island of the MGMT-promoter may correlate with outcome in a qualitative or quant...
Autores principales: | Siller, Sebastian, Lauseker, Michael, Karschnia, Philipp, Niyazi, Maximilian, Eigenbrod, Sabina, Giese, Armin, Tonn, Joerg-Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934240/ https://www.ncbi.nlm.nih.gov/pubmed/33663593 http://dx.doi.org/10.1186/s40478-021-01134-5 |
Ejemplares similares
-
Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
por: Teske, Nico, et al.
Publicado: (2021) -
O(6)-Methylguanine-DNA Methyltransferase (MGMT) mRNA
Expression Predicts Outcome in Malignant Glioma Independent of
MGMT Promoter Methylation
por: Kreth, Simone, et al.
Publicado: (2011) -
Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020) -
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status
por: Weller, Jonathan, et al.
Publicado: (2023) -
Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma
por: Teske, Nico, et al.
Publicado: (2023)